# Effects of Oral Mucolytics on Tear Film and Ocular Surface

> **NCT01713179** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hallym University Kangnam Sacred Heart Hospital** · enrollment: 20 (actual)

## Conditions studied

- In the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.

## Interventions

- **DRUG:** Ambroxol hydrochloride (Mucopect®, 60 mg, Boehringer Ingelheim)

## Key facts

- **NCT ID:** NCT01713179
- **Lead sponsor:** Hallym University Kangnam Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01713179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01713179, "Effects of Oral Mucolytics on Tear Film and Ocular Surface". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01713179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*